^
Association details:
Biomarker:No biomarker
Cancer:Pancreatic Adenocarcinoma
Regimen:CAPOX (capecitabine + oxaliplatin)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Pancreatic Adenocarcinoma: Preferred Regimens…Capecitabine+ Oxaliplatin Pancreatic Adenocarcinoma….PRINCIPLES OF SYSTEMIC THERAPY….Intermediate PS2….Other Recommended Regimens...CapeOx (category 2B)